Bassi 2015.
Methods | RCT, prospective, randomised, open‐label |
Participants | 34 patients with symptomatic uncomplicated diverticular disease |
Interventions | 5‐ASA mesalazine 1.6 g/d or mesalazine 1.6 g/d + L. casei DG 16 billion/d for 10 days/month for 18 months |
Outcomes | 4 participants (11.8%) were symptom free after the 12th month of treatment. |
Notes | Both mesalazine and L. casei seem to be effective in preventing recurrence of uncomplicated symptomatic diverticular disease of the colon. |